2001 Annual Report

Previous | Table of Contents | Next

Schedule C – Disbursements to Claimants and Related Funding Requirements

THE 1986-1990 HEPATITIS C FUND

Auditors' Report

To the Joint Committee of the 1986-1990 Hepatitis C Fund

We have audited the Hepatitis C Fund schedule of disbursements to claimants and related funding requirements for the six-month period ended September 30, 2000. This statement is the responsibility of the Administrator. Our responsibility is to express an opinion on this financial schedule based on our audit.

We conducted our audit in accordance with Canadian generally accepted auditing standards. Those standards require that we plan and perform an audit to obtain reasonable assurance whether the financial schedule is free of material misstatement. An audit includes examining, on a test basis, evidence supporting the amounts and disclosures in the financial schedule. An audit also includes assessing the accounting principles used and significant estimates made by management, as well as evaluating the overall financial schedule presentation.

In our opinion, this schedule presents fairly, in all material respects, the disbursements to claimants and related funding requirements of the Hepatitis C Fund for the six-month-period ended September 30, 2000.

Deloitte & Touche LLP
Chartered Accountants
Ottawa, Canada
November 28, 2000

Schedule C - Schedule of Disbursements to Claimants and Related Funding Requirements For the Six-Month Period Ended September 30, 2000 Prepared by Deloitte & Touche LLP.

The Hepatitis C Fund was established as a result of the Hepatitis C January 1, 1986 - July 1, 1999 class actions settlement. Its purpose is to make payments to persons recognized as claimants under the settlement. The disbursements to claimants and related funding requirements are administered by the Garden City Group Canada, a division of Crawford Canada.

Top